Op-Ed: It's time for the greater Houston area to embrace connectivity

guest column

Every stakeholder should be at the table: industry, city officials, businesses, and most importantly, the local community, to support the expansion of the local 5G network. Photo via Getty Images

We live in a digital first world where the need for fast, reliable connectivity is not just something people want--it’s a necessity.

Connectivity plays a key role in every facet of life from economic development to public safety. Tomorrow’s innovations will rely on today’s infrastructure. That means cities and states must keep their eyes and efforts firmly fixed on the most up-to-date technology and prepare for modern wireless services, including 5G technology, the fifth-generation wireless system, in order to stay ahead of the curve.

Many of us have seen television commercials and internet ads touting the benefits 5G will bring, particularly as it relates to speed and reliability. But 5G is much more than speed. It will pave the way for innovation across a broad range of industries, injecting trillions into the global economy and ultimately changing the way we work, get around the city and live our lives. 5G connectivity will be able to process mass amounts of data with little to no latency, a requirement for the technology of tomorrow.

The economic impact will also be significant. A report from Accenture found that 5G will greatly benefit the Texas economy in the next five years, bringing Texas an estimated $235.8 billion in additional sales, $130.5B in new GDP and 1.35M in potential jobs.

Cities that embrace this coming technological boom will find themselves better prepared to tackle challenges and address the needs of their residents. Take public safety for example: 80 percent of 911 calls originate from mobile devices, which rely on a network of infrastructure – towers, small cells and fiber. 5G will enable seamless data transfer between first responders and dispatchers, including the exact location of a call as well as medical history to EMS. It will create a seamless network to properly communicate to other emergency services like fire and police departments. An estimated 10,000 lives could be saved each year if emergency response times were reduced by one minute.

Relevant to Pasadena are the transformations 5G will bring to healthcare and manufacturing. 5G is revolutionizing advanced training for medical professionals and allows more remote post-acute care and home-based models as well as enhanced communication between medical professionals. This will ultimately drive better patient outcomes and cost savings greater than 30 percent. 5G will also increase capacity and security for Pasadena’s wide variety of manufacturers, from chemicals to electronics to food and textiles, as well as create safer, smarter and more efficient processes that will drive continued innovation.

The full potential of 5G requires communications infrastructure–towers, small cells and fiber—and modernized regulations from local and state governments. Without the right infrastructure and policies in place, communities in Texas - like Pasadena - won’t have access to the innovative technology and benefits that 5G will embolden.

Research has found that 78 percent of Texans support their city leadership taking faster action to implement 5G technology. Yet Pasadena city officials have spent countless hours and financial resources since September 2020 fighting a lawsuit to prevent 5G installations in this community. Those dollars could have been spent on real community needs like infrastructure, utilities and public works. Pasadena is now behind its peers across the greater Houston area, where we have witnessed thousands of successful deployments of this necessary communications infrastructure. This puts Pasadena at a disadvantage as a great place to do business and improve the lives of residents.

It’s time for Pasadena to embrace the smart city infrastructure of the future. Other Texas cities like in Houston, Dallas and San Antonio, or even neighboring La Porte, have initiated smart policies that have encouraged connectivity in their communities as well as investments from industry. Unfortunately, Pasadena’s connectivity and infrastructure are being impeded by local politics. Every stakeholder should be at the table: industry, city officials, businesses, and most importantly, the local community, to support the expansion of the local 5G network.

------

Scott Dunaway is a spokesperson for the Texas 5G Alliance.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

5 Houston scientists named winners of prestigious Hill Prizes 2026

prized research

Five Houston scientists were recognized for their "high-risk, high-reward ideas and innovations" by Lyda Hill Philanthropies and the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST).

The 2026 Hill Prizes provide seed funding to top Texas researchers. This year's prizes were given out in seven categories, including biological sciences, engineering, medicine, physical sciences, public health and technology, and the new artificial intelligence award.

Each recipient’s institution or organization will receive $500,000 in direct funding from Dallas-based Lyda Hill Philanthropies. The organization has also committed to giving at least $1 million in discretionary research funding on an ad hoc basis for highly-ranked applicants who were not selected as recipients.

“It is with great pride that I congratulate this year’s Hill Prizes recipients. Their pioneering spirit and unwavering dedication to innovation are addressing some of the most pressing challenges of our time – from climate resilience and energy sustainability to medical breakthroughs and the future of artificial intelligence,” Lyda Hill, founder of Lyda Hill Philanthropies, said in a news release.

The 2026 Houston-area recipients include:

Biological Sciences: Susan M. Rosenberg, Baylor College of Medicine

Rosenberg and her team are developing ways to fight antibiotic resistance. The team will use the funding to screen a 14,000-compound drug library to identify additional candidates, study their mechanisms and test their ability to boost antibiotic effectiveness in animal models. The goal is to move toward clinical trials, beginning with veterans suffering from recurrent infections.

Medicine: Dr. Raghu Kalluri, The University of Texas MD Anderson Cancer Center

Kalluri is developing eye drops to treat age-related macular degeneration (AMD), the leading cause of vision loss globally. Kalluri will use the funding to accelerate studies and support testing for additional ocular conditions. He was also named to the National Academy of Inventors’ newest class of fellows last month.

Engineering: Naomi J. Halas, Rice University

Co-recipeints: Peter J. A. Nordlander and Hossein Robatjazi, Rice University

Halas and her team are working to advance light-driven technologies for sustainable ammonia synthesis. The team says it will use the funding to improve light-driven catalysts for converting nitrogen into ammonia, refine prototype reactors for practical deployment and partner with industry collaborators to advance larger-scale applications. Halas and Nordlander are co-founders of Syzygy Plasmonics, and Robatjazi serves as vice president of research for the company.

The other Texas-based recipients include:

  • Artificial Intelligence: Kristen Grauman, The University of Texas at Austin
  • Physical Sciences: Karen L. Wooley, Texas A&M University; Co-Recipient: Matthew Stone, Teysha Technologies
  • Public Health: Dr. Elizabeth C. Matsui, The University of Texas at Austin and Baylor College of Medicine
  • Technology: Kurt W. Swogger, Molecular Rebar Design LLC; Co-recipients: Clive Bosnyak, Molecular Rebar Design, and August Krupp, MR Rubber Business and Molecular Rebar Design LLC

Recipients will be recognized Feb. 2 during the TAMEST 2026 Annual Conference in San Antonio. They were determined by a committee of TAMEST members and endorsed by a committee of Texas Nobel and Breakthrough Prize Laureates and approved by the TAMEST Board of Directors.

“On behalf of TAMEST, we are honored to celebrate the 2026 Hill Prizes recipients. These outstanding innovators exemplify the excellence and ambition of Texas science and research,” Ganesh Thakur, TAMEST president and a distinguished professor at the University of Houston, added in the release. “Thanks to the visionary support of Lyda Hill Philanthropies, the Hill Prizes not only recognize transformative work but provide the resources to move bold ideas from the lab to life-changing solutions. We are proud to support their journeys and spotlight Texas as a global hub for scientific leadership.”

Investment bank opens new Houston office focused on energy sector

Investment bank Cohen & Co. Capital Markets has opened a Houston office to serve as the hub of its energy advisory business and has tapped investment banking veteran Rahul Jasuja as the office’s leader.

Jasuja joined Cohen & Co. Capital Markets, a subsidiary of financial services company Cohen & Co., as managing director, and head of energy and energy transition investment banking. Cohen’s capital markets arm closed $44 billion worth of deals last year.

Jasuja previously worked at energy-focused Houston investment bank Mast Capital Advisors, where he was managing director of investment banking. Before Mast Capital, Jasuja was director of energy investment banking in the Houston office of Wells Fargo Securities.

“Meeting rising [energy] demand will require disciplined capital allocation across traditional energy, sustainable fuels, and firm, dispatchable solutions such as nuclear and geothermal,” Jasuja said in a news release. “Houston remains the center of gravity where capital, operating expertise, and execution come together to make that transition investable.”

The Houston office will focus on four energy verticals:

  • Energy systems such as nuclear and geothermal
  • Energy supply chains
  • Energy-transition fuel and technology
  • Traditional energy
“We are making a committed investment in Houston because we believe the infrastructure powering AI, defense, and energy transition — from nuclear to rare-earth technology — represents the next secular cycle of value creation,” Jerry Serowik, head of Cohen & Co. Capital Markets, added in the release.

---

This article originally appeared on EnergyCaptialHTX.com.

MD Anderson makes AI partnership to advance precision oncology

AI Oncology

Few experts will disagree that data-driven medicine is one of the most certain ways forward for our health. However, actually adopting it comes at a steep curve. But what if using the technology were democratized?

This is the question that SOPHiA GENETICS has been seeking to answer since 2011 with its universal AI platform, SOPHiA DDM. The cloud-native system analyzes and interprets complex health care data across technologies and institutions, allowing hospitals and clinicians to gain clinically actionable insights faster and at scale.

The University of Texas MD Anderson Cancer Center has just announced its official collaboration with SOPHiA GENETICS to accelerate breakthroughs in precision oncology. Together, they are developing a novel sequencing oncology test, as well as creating several programs targeted at the research and development of additional technology.

That technology will allow the hospital to develop new ways to chart the growth and changes of tumors in real time, pick the best clinical trials and medications for patients and make genomic testing more reliable. Shashikant Kulkarni, deputy division head for Molecular Pathology, and Dr. J. Bryan, assistant professor, will lead the collaboration on MD Anderson’s end.

“Cancer research has evolved rapidly, and we have more health data available than ever before. Our collaboration with SOPHiA GENETICS reflects how our lab is evolving and integrating advanced analytics and AI to better interpret complex molecular information,” Dr. Donna Hansel, division head of Pathology and Laboratory Medicine at MD Anderson, said in a press release. “This collaboration will expand our ability to translate high-dimensional data into insights that can meaningfully advance research and precision oncology.”

SOPHiA GENETICS is based in Switzerland and France, and has its U.S. offices in Boston.

“This collaboration with MD Anderson amplifies our shared ambition to push the boundaries of what is possible in cancer research,” Dr. Philippe Menu, chief product officer and chief medical officer at SOPHiA GENETICS, added in the release. “With SOPHiA DDM as a unifying analytical layer, we are enabling new discoveries, accelerating breakthroughs in precision oncology and, most importantly, enabling patients around the globe to benefit from these innovations by bringing leading technologies to all geographies quickly and at scale.”

View All Listings